Global Leprosy Market, By Type (Borderline Lepromatous Leprosy, Borderline Tuberculoid Leprosy, Indeterminate Leprosy, Lepromatous Leprosy, Midborderline Leprosy, Tuberculoid Leprosy, Others), Treatment (Diagnosis, Medication, Others), Population (Children, Adults), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Leprosy Market
Global Leprosy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 3.50% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.
Moreover, technological advancement in treatment and diagnosis and rising prevalence of leprosy also boost up the market growth. Continuous rising government awareness programmes and expanding pool of patients suffering from leprosy all over the world also boost up the market growth. Increasing new treatment options act as opportunity for the market growth. But, least availability of medical facilities, lack of awareness and presence of alternative treatment may hamper the global leprosy market.
Leprosy is a serious infectious diseases caused by the bacillus known as Mycobacterium leprae. Leprosy causes severe, disfiguring skin sores and nerve damage in the arms, legs, and skin areas around the body. The bacillus Mycobacterium leprae multiplies slowly and the incubation period of the disease, on average, is 5 years. The symptoms of the leprosy occurs within I year but sometimes it will take as long as 20 years or more.
According to WHO in 2018, globally 208,619 new leprosy cases registered. The data from 159 countries from the 6 WHO regions. The registered prevalence of leprosy is less than 1 case per 10 000 population. Moreover, according to the National Organization of Rare Disease in the U.S. approximately 7,000 people have been treated for the disease and annually 150-200 new cases were reported. Some of the major countries with highest leprosy cases are India, Brazil, Indonesia, Bangladesh, Myanmar, Nigeria, and Mozambique.
This leprosy market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Leprosy Market Scope and Market Size
The leprosy market is segmented on the basis of type, treatment, population, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the leprosy market is segmented into borderline lepromatous leprosy, borderline tuberculoid leprosy, indeterminate leprosy, lepromatous leprosy, midborderline leprosy, tuberculoid leprosy and others.
- On the basis of treatment, the leprosy market is segmented into diagnosis, medication and others. Diagnosis segment further divided into skin smear test and others. Medication segment further divided into dapsone, rifampin, clofazimine, minocycline, oflaxacin, clarithromycin, prednisone, thalidomide and others.
- On the basis of population, the leprosy market is segmented into children and adults.
- On the basis of end-users, the leprosy market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the leprosy market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Leprosy Market Country Level Analysis
Leprosy market is analysed and market size information is provided by country, type, treatment, population, end-users and distribution channel as referenced above.
The countries covered in the leprosy market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to the presence of high healthcare expenditure and increased clinical studies for the treatment. Asia-Pacific is expected to account for the largest market share over coming years for the Leprosy market due to constant rise in the incidence of leprosy and rising demand for cost-efficient therapeutics.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Leprosy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Leprosy Market Share Analysis
Leprosy market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to leprosy market.
The major players covered in the Leprosy market are Leo Pharma A/s, GlaxoSmithKline plc, Pfizer Inc., Mylan N.V., Macleods Pharmaceuticals, Cadila Pharmaceuticals, Johnson & Johnson Services, Inc. Teva Pharmaceutical Industries Ltd., Bayer AG, Galderma S.A., Sun Pharmaceutical Industries Ltd., Perrigo Pharmaceutical plc., Novartis AG, AstraZeneca plc, Sanofi among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-